Polar Capital fund manager Dan Mahony examines how technology is transforming the global healthcare system.
Our favourite US broker is convinced the healthcare sector is a strong buy and is about to enjoy an extended period of significant outperformance. He is not a sector specialist and bases most of his calls on technical analysis, but he rarely succumbs to hyperbole, and so it is worth listening when he makes such a claim. His rationale is simply this: stocks or sectors that break out from a trading range after a significant period of consolidation should be bought as they offer significant upside potential. Moreover, a longer period of consolidation is associated with far greater and mo...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes